Salima Akter, Ph.D. is a biomedical scientist with broad expertise in cancer biology, metabolic diseases, and molecular medicine. Her research centers on identifying and validating prognostic and predictive biomarkers using clinical samples and large-scale genomic and transcriptomic datasets, with a particular focus on the insulin/IGF axis, diabetes-associated cancers, and triple-negative breast cancer. She integrates molecular biology, in vivo and in vitro experimentation, and bioinformatics to understand tumor progression, metastasis, and therapeutic resistance. Her academic interests also include metabolic syndrome, type 2 diabetes, obesity-related cancer risk, and age-related neurodegenerative diseases.